Some service members and others suffering from Post-Traumatic Stress Disorder (PTSD) have had little relief from traditional anti-depressants used in conjunction with psychotherapy. Now, a recent FDA-approved trial using a psychedelic drug called MDMA – better known by its street name, ecstasy – has shown promising results. CBS News national security correspondent David Martin talks with a former Marine whose two tours in Iraq presaged twelve years of nightmares, panic attacks and failed relationships – and who now finds hope. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.